CHANGES IN SEROTONIN METABOLISM IN CANCER-PATIENTS - ITS RELATIONSHIP TO NAUSEA AND VOMITING INDUCED BY CHEMOTHERAPEUTIC DRUGS

被引:106
作者
CUBEDDU, LX [1 ]
HOFFMANN, IS [1 ]
FUENMAYOR, NT [1 ]
MALAVE, JJ [1 ]
机构
[1] PEREZ CARRENO HOSP,CARACAS,VENEZUELA
关键词
D O I
10.1038/bjc.1992.242
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The metabolism of serotonin was studied in cancer patients of their first day of their first course of chemotherapeutic drugs either with strongly or moderately emetogenic regimens. It was observed that strongly emetogenic treatments induce greater increases in serotonin release than moderately emetogenic regimens. High-dose cisplatinum (75+/-5 or 83.8+/-5 mg m-2) produced a marked increase in the plasma levels and in the urinary excretion of 5-hydroxyindole acetic acid (5-HIAA). Neither platelet nor plasma (platelet-free plasma) serotonin were significantly modified by high-dose cisplatinum. Dacarbazine (283+/-22 mg m-2), another strongly emetogenic agent, induced acute nausea and emesis paralleled by marked increases in the urinary excretion of 5-HIAA. Both for high-dose cisplatinum and dacarbazine, the increases in serotonin metabolism occurred with a similar time-course than those of vomiting, and lasted for a period of 4 to 8 h. Low-dose cisplatinum (30.8+/-3 mg m-2) as well as cyclophosphamide-based chemotherapies (520+/-30 mg m-2) produced very small increases in thc urinary excretion of 5-HIAA. Platelet and plasma serotonin levels failed to increase in cyclophosphamide-treated patients. Octreotide, a long-acting somatostatin analog, did not inhibit the increase in urinary 5-HIAA and the nausea and vomiting produced by high-dose cisplatinum. These results suggest that for treatments that induce marked increases in serotonin release such as high-dose cisplatinum or dacarbazine: (a) the amount and time course of serotonin release induced by chemotherapeutic drugs determines the severity, time of onset and pattern of emesis observed; (b) platelet serotonin play no role in chemotherapy-induced emesis; (c) strongly emetogenic regimens release serotonin from enterochromaffin cells; and (d) intestinal release of serotonin is the consequence of the damage induced by the chemotherapeutic drugs on the gut mucosa.
引用
收藏
页码:198 / 203
页数:6
相关论文
共 34 条
[1]
NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY [J].
ANDREWS, PLR ;
RAPEPORT, WG ;
SANGER, GJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) :334-341
[2]
BARNES N M, 1987, British Journal of Pharmacology, V92, p649P
[3]
TISSUE 5-HYDROXYTRYPTAMINE AND URINARY 5-HYDROXYINDOLEACETIC ACID AFTER PARTIAL OR TOTAL REMOVAL OF THE GASTRO-INTESTINAL TRACT IN THE RAT [J].
BERTACCINI, G .
JOURNAL OF PHYSIOLOGY-LONDON, 1960, 153 (02) :239-249
[4]
5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONISM TO PREVENT CISPLATIN-INDUCED EMESIS [J].
COSTALL, B ;
DOMENEY, AM ;
NAYLOR, RJ ;
TATTERSALL, FD .
NEUROPHARMACOLOGY, 1986, 25 (08) :959-961
[5]
ANTAGONISM OF SEROTONIN-S3 RECEPTORS WITH ONDANSETRON PREVENTS NAUSEA AND EMESIS INDUCED BY CYCLOPHOSPHAMIDE-CONTAINING CHEMOTHERAPY REGIMENS [J].
CUBEDDU, LX ;
HOFFMAN, IS ;
FUENMAYOR, NT ;
FINN, AL .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) :1721-1727
[6]
EFFICACY OF ONDANSETRON (GR-38032F) AND THE ROLE OF SEROTONIN IN CISPLATIN-INDUCED NAUSEA AND VOMITING [J].
CUBEDDU, LX ;
HOFFMANN, IS ;
FUENMAYOR, NT ;
FINN, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (12) :810-816
[7]
ENCK RE, 1977, LANCET, V1, P927
[8]
OBSERVATIONS ON THE RELEASE AND TURNOVER RATE OF 5-HYDROXYTRYPTAMINE IN THE GASTROINTESTINAL TRACT [J].
ERSPAMER, V ;
TESTINI, A .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1959, 11 (10) :618-623
[9]
ERSPAMER V, 1954, REND SCIENT FARMITAL, V1, P1
[10]
FELDBERG W, 1953, J PHYSIOL-LONDON, V119, P352, DOI 10.1113/jphysiol.1953.sp004850